Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Sales (2021 - 2025)

Historic Return on Sales for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 1.61%.

  • Molecular Partners Ag's Return on Sales rose 150400.0% to 1.61% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.27%, marking a year-over-year increase of 106233000.0%. This contributed to the annual value of 10.81% for FY2024, which is 88548463300.0% up from last year.
  • Per Molecular Partners Ag's latest filing, its Return on Sales stood at 1.61% for Q3 2025, which was up 150400.0% from 2.27% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Return on Sales ranged from a high of 138.23% in Q4 2023 and a low of 5791820.5% during Q1 2024
  • Over the past 5 years, Molecular Partners Ag's median Return on Sales value was 3.63% (recorded in 2021), while the average stood at 565192.44%.
  • As far as peak fluctuations go, Molecular Partners Ag's Return on Sales plummeted by 2000000000bps in 2023, and later surged by 2000000000bps in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Return on Sales stood at 6.0% in 2021, then surged by 110bps to 0.62% in 2022, then skyrocketed by 22141bps to 138.23% in 2023, then plummeted by -99bps to 1.45% in 2024, then crashed by -212bps to 1.61% in 2025.
  • Its last three reported values are 1.61% in Q3 2025, 2.27% for Q2 2025, and 12.86% during Q1 2025.